Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sawsan M Moeen"'
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 31, Iss 4, Pp 741-745 (2019)
Background The combination of beta-thalassemia trait (BTT) and iron-deficiency anemia (IDA) is an interesting common issue in our country. However, treatment of this condition is challenging. Objectives This prospective observational study was design
Externí odkaz:
https://doaj.org/article/f90f59bfceed45b1849ad7737eb68e69
Autor:
Osama Ahmed Ibrahiem, Ahmad F. Thabet, Shymaa S. Tony, Kerollos Motwade N. Kerollos, Sawsan M. Moeen
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 34, Iss 1, Pp 1-9 (2022)
Abstract Background Hemophilia is an inherited condition that is caused by the deficiency of clotting factors in the blood. The most common presentations of hemophilia are hemarthrosis and muscle hemorrhage. The severity of the bleeding episodes can
Externí odkaz:
https://doaj.org/article/eaee4548b9c1455b9cdb902d99351264
Autor:
Ghada E. M. Abdallah, Esam A. S. Elbiih, Douaa Sayed, Sawsan M. Moeen, Shima Gafer, Ahmad F. Thabet
Publikováno v:
Platelets, Vol 32, Iss 2, Pp 243-249 (2021)
The balance between therapy effectiveness and economic efficiency in chronic immune thrombocytopenia (ITP) becomes more confusing. This single-center open label randomized controlled trial evaluates the effectiveness and safety of hydroxychloroquine
Externí odkaz:
https://doaj.org/article/adf9fcb72f4246bf84b0b21f47e092b1
Autor:
Ahmad F. Thabet, Sawsan M. Moeen
Publikováno v:
Platelets, Vol 31, Iss 6, Pp 784-787 (2020)
Treatment of chronic primary immune thrombocytopenia (ITP) is challenging especially with limited resources and therapy-related complications. This prospective interventional study assessed the efficacy and safety of triple therapy(TT4); a combinatio
Externí odkaz:
https://doaj.org/article/252c1538e21e4e23b8a070e11043814a
Autor:
Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady
Publikováno v:
African Journal of Laboratory Medicine, Vol 10, Iss 1, Pp e1-e8 (2021)
Background: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating
Externí odkaz:
https://doaj.org/article/813eadb309c54aef8d01b5cb7af0684e
Autor:
Hanan O. Mohamed, Sahar A. Elgammal, Sawsan M. Moeen, Eman A. Yousof, Doaa M. Sayed, Eman H. Ahmed, Shymaa G. Mansor, Salah M. Khallaf
Publikováno v:
Research in Oncology, Vol 16, Iss 1, Pp 6-10 (2020)
Background: Understanding the prognostic markers of multiple myeloma (MM) helps in optimizing therapeutic approaches. CD56 is frequently expressed by malignant plasma cells and its use as a prognostic marker in MM is promising. Aim: To evaluate progn
Autor:
Ahmad F. Thabet, Sawsan M. Moeen
Publikováno v:
Platelets. 31:784-787
Treatment of chronic primary immune thrombocytopenia (ITP) is challenging especially with limited resources and therapy-related complications. This prospective interventional study assessed the efficacy and safety of triple therapy(TT4); a combinatio
Autor:
Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady
Publikováno v:
African Journal of Laboratory Medicine, Volume: 11, Issue: 1, Pages: 1-1, Published: 2022
Autor:
Sawsan M. Moeen, Mohammed M Wahman, Hanaa Nafady-Hego, Hanan A. Eltyb, Asmaa M Zahran, Asmaa Nafady
Publikováno v:
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Vol 10, Iss 1, Pp e1-e8 (2021)
African Journal of Laboratory Medicine, Vol 10, Iss 1, Pp e1-e8 (2021)
Background: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating
Autor:
Shima Gafer, Esam A. S. Elbiih, Douaa Sayed, Ahmad F. Thabet, Sawsan M. Moeen, Ghada E.M. Abdallah
Publikováno v:
Platelets. 32(2)
The balance between therapy effectiveness and economic efficiency in chronic immune thrombocytopenia (ITP) becomes more confusing. This single-center open label randomized controlled trial evaluates the effectiveness and safety of hydroxychloroquine